Angiography is a medical test that examines the inside of the body's blood vessels. This test helps doctors determine if there are blockages, narrowings, or other problems in the veins. This test is ...
When a Cardiologist tells you that you have“90 percent blockage,” the mind goes straight to fear. Most families immediately ask three questions. Is this a heart attack. Do I need a stent right now.
Pharrell’s Louis Vuitton is all about disruption in the context of tradition; breaking the norm while paying homage to the house’s storied style codes and history. The latest venture for Louis Vuitton ...
Abstract: Accurate delineation of the left ventricle (LV) is an important step in evaluation of cardiac function. In this paper, we present an automatic method for segmentation of the LV in cardiac CT ...
A peripheral angiogram is a test that checks for blockages in the arteries that supply blood to your legs and feet or your arms and hands. These arteries are called peripheral arteries because they ...
Washington, D.C. – May 1, 2025 – New technology shows promise for restoring blood flow and advancing care for patients with pulmonary embolism (PE) and carotid artery stenosis (CAS). The data were ...
Peer-reviewed data highlights successful clinical study with 35.5% clot burden reduction, validating the safety, efficacy, and efficiency of AlphaVac F18 85 System in pulmonary embolism treatment.
Abstract: Coronary X-ray angiography has proven to be an efficient method for treatment and diagnosis of cardiovascular diseases. In clinical practice, quantitative LV analysis is done in 2-D and ...
FRIDAY, Sept. 20, 2024 (HealthDay News) -- For patients with heart failure with preserved ejection fraction (HFpEF), endovascular treatment (EVT) improves left ventricular (LV) diastolic function, ...
The process influenced a new scent developed by the “Happy” singer for Louis Vuitton. Plus, a surprise at Valentino and a punk doyenne’s wardrobe at auction. By Ruth La Ferla In the Fashion Chatter ...
Long Beach, Calif. – May 3, 2024 – Late-breaking data from the ENGULF trial showed that a novel dual-action thrombectomy device was effective and safe in treating acute pulmonary embolism (PE). The ...